ICU Medical Announces Time of Second Quarter 2025 Earnings Conference Call
Rhea-AI Summary
ICU Medical (Nasdaq: ICUI), a leading medical products manufacturer, has scheduled its second quarter 2025 earnings release and conference call. The company will release Q2 2025 results on Thursday, August 7, 2025, at 4:00 p.m. ET, followed by a conference call at 4:30 p.m. ET.
Investors can access the call via phone at (800) 267-6316 using conference ID "ICUMED" or through a webcast available on the company's website. The webcast will also be available for replay through ICU Medical's investor relations section at www.icumed.com.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, ICUI gained 0.14%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
SAN CLEMENTE, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its second quarter 2025 earnings release and conference call.
The Company will release its second quarter 2025 results on Thursday, August 7, 2025 at approximately 4:00 p.m. ET (1:00 p.m. PT) and will be conducting a conference call concerning those results at 4:30 p.m. ET (1:30 p.m. PT) on Thursday, August 7, 2025. The call can be accessed at (800) 267-6316, conference ID “ICUMED”. The conference call will be simultaneously available by webcast, which can be accessed by going to the Company's website at www.icumed.com, clicking on the Investors tab, clicking on the Webcast icon and following the prompts. The webcast will also be available by replay.
About ICU Medical
ICU Medical (Nasdaq: ICUI) is a global leader in infusion systems, infusion consumables and high-value critical care products used in hospital, alternate site and home care settings. Our team is focused on providing quality, innovation and value to our clinical customers worldwide. ICU Medical is headquartered in San Clemente, California. More information about ICU Medical can be found at www.icumed.com.
CONTACT:
ICU Medical, Inc.
Brian Bonnell, Chief Financial Officer
(949) 366-2183
ICR, Inc.
John Mills, Managing Partner
(646) 277-1254
Source: ICU Medical, Inc.
FAQ
When is ICU Medical (ICUI) releasing its Q2 2025 earnings?
How can investors join ICU Medical's Q2 2025 earnings call?
What time is ICU Medical's Q2 2025 earnings conference call?
Will ICU Medical's Q2 2025 earnings call be available for replay?
